ArticleJournal of the American Pharmacists Association : JAPhA
Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
Article in Journal of the American Pharmacists Association : JAPhA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of medication therapy management programs on potentially inappropriate medication use in older adults: A systematic review.Journal of managed care & specialty pharmacy · 2024Pooled it
- Characterizing Medicare Medication Therapy Management program enrollees with central nervous system-active polypharmacy.Journal of managed care & specialty pharmacy · 2026Observational
- Trends in delivery of comprehensive medication reviews by race and ethnicity, 2013-2021.Journal of managed care & specialty pharmacy · 2025Article
- Receipt of Medicare Part D comprehensive medication reviews in older adults with dementia.Journal of managed care & specialty pharmacy · 2025Article
- Perception, concerns, and practice of ChatGPT among Egyptian pharmacists: a cross-sectional study in Egypt.BMC health services research · 2024Article
- Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.Journal of managed care & specialty pharmacy · 2024Article
- Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.JAMA health forum · 2024Observational
- Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.Exploratory research in clinical and social pharmacy · 2024Article
- Challenges in Deprescribing among Older Adults in Post-Acute Care Transitions to Home.Journal of the American Medical Directors Association · 2024Article
- Applying the Andersen behavioral model to the medication therapy management program: an approach for improving medication safety in older adults.Frontiers in public health · 2024Article
- ChatGPT in pharmacy practice: a cross-sectional exploration of Jordanian pharmacists' perception, practice, and concerns.Journal of pharmaceutical policy and practice · 2023Article
- Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.Exploratory research in clinical and social pharmacy · 2023Article
- Predictors of Receipt of Comprehensive Medication Reviews in Older Adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023Article
- Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer's disease.Current medical research and opinion · 2021Article
- Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.Exploratory research in clinical and social pharmacy · 2021Article
- Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.American health & drug benefits · 2021Article
- Medication Therapy Management: Current Challenges.Integrated pharmacy research & practice · 2020Review
- Primary healthcare policy and vision for community pharmacy and pharmacists in the United States.Pharmacy practiceArticle
- Bridging the knowledge gap: Med Wise Rx helps older adults navigate comprehensive medication reviews.Journal of the American Pharmacists Association : JAPhAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo describe the national delivery of medication therapy management (MTM) to Medicare beneficiaries in 2013 and 2014.
methodsDescriptive cross-sectional study using the 100% sample of 2013 and 2014 Part D MTM data files. We quantified descriptive statistics (counts and percentages, in addition to means and standard deviations) to summarize the delivery of these services and compare delivery between 2013 and 2014.
resultsMedicare beneficiaries eligible for MTM increased from 4,281,733 in 2013 to 4,552,547 in 2014. Among eligible beneficiaries, the number and percentage who were offered a comprehensive medication review (CMR) increased from 3,473,004 (81.1%) to 4,394,822 (96.5%), and beneficiaries receiving a CMR increased from 526,203 (12.3%) to 767,286 (16.9%). In 2014, CMRs were most frequently delivered by telephone (83.2%) and provided by either a plan sponsor (29.0%) or an MTM vendor in-house pharmacist (35.0%). In 2014, pharmacists provided 93.5% of all CMRs, and other providers (e.g., nurses and physicians) provided 6.5% of CMRs. Few patients who received a CMR received more than 1 within the same year (2.2% in 2014). Medication therapy problem (MTP) resolution among patients receiving a CMR stayed roughly the same between 2013 and 2014 (19.2% vs. 18.7%, respectively; P < 0.001). Finally, most beneficiaries (96.9% in 2014) received a targeted medication review, regardless of whether a CMR was offered or provided.
conclusionMore than 4 million Medicare beneficiaries were enrolled in Part D MTM in both 2013 and 2014. However, less than 20% of eligible beneficiaries received a CMR during those years, and rates of MTP resolution were low. Future evaluation of Part D MTM delivery should examine changes in eligibility criteria and delivery over time to inform MTM policy and changes in practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.